National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Extracranial Germ Cell Tumors Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 02/26/2008
Table 3: Standard Treatment Approaches for Infants and Children Younger Than 15 Years With Germ Cell Tumors by Histology, Stage, and Primary Site

Histology   Primary Site   Stage   Treatment 
Mature teratoma All sites Localized Surgery + Observation
Immature teratoma All sites Localized Surgery + Observation
Malignant germ cell tumors Testicular Stage I Surgery + Observation
Stages II–IV* Surgery + PEB
Ovarian Stage I Surgery + Observation
Stages II–IV Surgery + PEB
Extragonadal Stages I–II Surgery** + PEB
Stages III–IV* Surgery** + PEB

*Patients ≥15 years with stage IV testicular tumors and all patients with stages III and IV extragonadal tumors treated with PEB have suboptimal outcome and should be considered for more intensive therapies.
**The role for surgery at diagnosis for extragonadal tumors is age- and site-dependent and must be individualized. Depending on the clinical setting, the appropriate surgical approach may range from no surgery (e.g., mediastinal primary tumor in a patient with a compromised airway and elevated tumor markers), to biopsy, to primary resection. In some cases, an appropriate strategy is biopsy at diagnosis followed by subsequent surgery in selected patients who have residual masses following chemotherapy.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov